M330-0074 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-methyl-5-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-1H-pyrrole-3-sulfonamide

M330-0074 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-methyl-5-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-1H-pyrrole-3-sulfonamide
M330-0074 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-methyl-5-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-1H-pyrrole-3-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M330-0074
N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-methyl-5-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-1H-pyrrole-3-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M330-0074

Molecular Formula

C22H24N4O5S2 (C22 H24 N4 O5 S2)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-methyl-5-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-1H-pyrrole-3-sulfonamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-1-methyl-5-[4-methyl-5-(pyrrolidine-1-carbonyl)-13-thiazol-2-yl]-1H-pyrrole-3-sulfonamide

SMILES

Cc1c(C(N2CCCC2)=O)sc(-c2cc(S(NCc(cc3)cc4c3OCO4)(=O)=O)cn2C)n1

InChI

InChI=1S/C22H24N4O5S2/c1-14-20(22(27)26-7-3-4-8-26)32-21(24-14)17-10-16(12-25(17)2)33(28,29)23-11-15-5-6-18-19(9-15)31-13-30-18/h5-6,9-10,12,23H,3-4,7-8,11,13H2,1-2H3

InChI Key

DFHMOJZOYWKYRH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27536174

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

488.59

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.171

Distribution Coefficient, logD

3.171

Water Solubility, LogSw

-3.38

Polar Surface Area

88.747

Acid Dissociation Constant (pKa)

10.68

Base Dissociation Constant (pKb)

0.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.40

M330-0074 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with M330-0074 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M330-0074?
Check Price and Availability of M330-0074, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M330-0074 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M330-0074
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M330-0074
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M330-0074 available by request